speb/financial-data huggingface dataset:
ORGO income_statement (annual, 2022-12-31) — Net Interest Income: -2009000.00
ORGO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -3013000.00
ORGO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -3013000.00
ORGO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2009000.00
ORGO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1256000.00
ORGO balance_sheet (annual, 2022-12-31) — Net PPE: 145655000.00
ORGO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -33898000.00
ORGO cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
ORGO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 216108000.00
ORGO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 30014000.00
ORGO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 30014000.00
ORGO income_statement (annual, 2022-12-31) — Normalized EBITDA: 40322000.00
ORGO income_statement (annual, 2022-12-31) — Normalized Income: 15532000.00
ORGO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 24859000.00
ORGO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 4482000.00
ORGO income_statement (annual, 2022-12-31) — Operating Income: 22304000.00
ORGO income_statement (annual, 2022-12-31) — Operating Revenue: 450893000.00
ORGO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 130919129.00
ORGO balance_sheet (annual, 2022-12-31) — Other Current Assets: 4291000.00
ORGO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 4538000.00
ORGO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 926000.00
ORGO income_statement (annual, 2022-12-31) — Other Income Expense: -13000.00
ORGO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 20789000.00
ORGO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 10583000.00
ORGO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1520000.00
ORGO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1122000.00
ORGO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -13000.00
ORGO balance_sheet (annual, 2022-12-31) — Other Properties: 43192000.00
ORGO income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
ORGO balance_sheet (annual, 2022-12-31) — Payables: 34955000.00
ORGO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 40738000.00
ORGO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 17113000.00
ORGO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
ORGO cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
ORGO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 795000.00
ORGO income_statement (annual, 2022-12-31) — Pretax Income: 20282000.00
ORGO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 2070000.00
ORGO balance_sheet (annual, 2022-12-31) — Properties: 0.00
ORGO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 1781000.00
ORGO cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
ORGO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -33898000.00
ORGO balance_sheet (annual, 2022-12-31) — Raw Materials: 12282000.00
ORGO balance_sheet (annual, 2022-12-31) — Receivables: 89450000.00
ORGO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 105019000.00
ORGO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 18031000.00
ORGO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -3013000.00
ORGO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
ORGO income_statement (annual, 2022-12-31) — Research And Development: 39762000.00
ORGO balance_sheet (annual, 2022-12-31) — Restricted Cash: 812000.00
ORGO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
ORGO balance_sheet (annual, 2022-12-31) — Retained Earnings: -45301000.00
ORGO income_statement (annual, 2022-12-31) — Selling General And Administration: 283808000.00
ORGO balance_sheet (annual, 2022-12-31) — Share Issued: 131647677.00
ORGO income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
ORGO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 6552000.00
ORGO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 265669000.00
ORGO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 216108000.00
ORGO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ORGO income_statement (annual, 2022-12-31) — Tax Provision: 4750000.00
ORGO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
ORGO balance_sheet (annual, 2022-12-31) — Total Assets: 449359000.00
ORGO balance_sheet (annual, 2022-12-31) — Total Capitalization: 331900000.00
ORGO balance_sheet (annual, 2022-12-31) — Total Debt: 123791000.00
ORGO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 265669000.00
ORGO income_statement (annual, 2022-12-31) — Total Expenses: 428589000.00
ORGO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 183690000.00
ORGO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 226750000.00
ORGO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 108667000.00
ORGO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 22304000.00
ORGO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 2625000.00
ORGO income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
ORGO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ORGO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 728548.00
ORGO balance_sheet (annual, 2022-12-31) — Work In Process: 1022000.00
ORGO balance_sheet (annual, 2022-12-31) — Working Capital: 147586000.00
ORGO income_statement (annual, 2022-12-31) — Write Off: 0.00
ORGO income_statement (annual, 2023-12-31) — +Operating Expense: 314134000.00
ORGO income_statement (annual, 2023-12-31) — +Total Revenue: 433140000.00
ORGO balance_sheet (annual, 2023-12-31) — Accounts Payable: 30724000.00
ORGO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 81999000.00
ORGO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -73186000.00
ORGO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 319621000.00
ORGO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -6860000.00
ORGO cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 4918000.00
ORGO cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 4918000.00
ORGO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
ORGO income_statement (annual, 2023-12-31) — Basic Average Shares: 131231317.00
ORGO income_statement (annual, 2023-12-31) — Basic EPS: 0.04
ORGO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 103290000.00
ORGO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 4943000.00
ORGO cash_flow (annual, 2023-12-31) — Capital Expenditure: -24364000.00
ORGO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 53120000.00
ORGO balance_sheet (annual, 2023-12-31) — Capital Stock: 13000.00
ORGO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 103840000.00
ORGO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 103840000.00
ORGO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -5505000.00
ORGO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -24364000.00
ORGO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 30917000.00
ORGO cash_flow (annual, 2023-12-31) — Change In Account Payable: -108000.00
ORGO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 3138000.00
ORGO cash_flow (annual, 2023-12-31) — Change In Inventory: -8179000.00
ORGO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 91000.00
ORGO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -8439000.00
ORGO cash_flow (annual, 2023-12-31) — Change In Payable: -108000.00
ORGO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 3030000.00
ORGO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -10115000.00
ORGO cash_flow (annual, 2023-12-31) — Change In Receivables: 5539000.00
ORGO cash_flow (annual, 2023-12-31) — Change In Working Capital: -18073000.00
ORGO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 5539000.00
ORGO cash_flow (annual, 2023-12-31) — Changes In Cash: 1048000.00
ORGO balance_sheet (annual, 2023-12-31) — Common Stock: 13000.00
ORGO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 278663000.00
ORGO cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
ORGO balance_sheet (annual, 2023-12-31) — Construction In Progress: 59067000.00
ORGO income_statement (annual, 2023-12-31) — Cost Of Revenue: 106481000.00
ORGO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 7901000.00
ORGO balance_sheet (annual, 2023-12-31) — Current Assets: 225044000.00
ORGO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 14225000.00
ORGO balance_sheet (annual, 2023-12-31) — Current Debt: 5486000.00
ORGO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 19711000.00
ORGO balance_sheet (annual, 2023-12-31) — Current Liabilities: 80509000.00
ORGO cash_flow (annual, 2023-12-31) — Deferred Income Tax: 2012000.00
ORGO cash_flow (annual, 2023-12-31) — Deferred Tax: 2012000.00
ORGO cash_flow (annual, 2023-12-31) — Depreciation: 18531000.00
ORGO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 23449000.00
ORGO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 23449000.00
ORGO income_statement (annual, 2023-12-31) — Diluted Average Shares: 132746727.00
ORGO income_statement (annual, 2023-12-31) — Diluted EPS: 0.04
ORGO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 4945000.00
ORGO income_statement (annual, 2023-12-31) — EBIT: 12582000.00
ORGO income_statement (annual, 2023-12-31) — EBITDA: 36031000.00
ORGO cash_flow (annual, 2023-12-31) — End Cash Position: 104338000.00
ORGO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -5505000.00
ORGO balance_sheet (annual, 2023-12-31) — Finished Goods: 14455000.00
ORGO cash_flow (annual, 2023-12-31) — Free Cash Flow: 6553000.00
ORGO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 235000.00
ORGO balance_sheet (annual, 2023-12-31) — Goodwill: 28772000.00
ORGO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 44643000.00
ORGO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 88859000.00
ORGO balance_sheet (annual, 2023-12-31) — Gross PPE: 229532000.00
ORGO income_statement (annual, 2023-12-31) — Gross Profit: 326659000.00
ORGO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
ORGO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 3052000.00
ORGO income_statement (annual, 2023-12-31) — Interest Expense: 2190000.00
ORGO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2190000.00
ORGO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 5436000.00
ORGO balance_sheet (annual, 2023-12-31) — Inventory: 28253000.00
ORGO balance_sheet (annual, 2023-12-31) — Invested Capital: 344894000.00
ORGO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -24364000.00
ORGO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
ORGO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
ORGO balance_sheet (annual, 2023-12-31) — Leases: 60819000.00
ORGO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 38895000.00
ORGO balance_sheet (annual, 2023-12-31) — Long Term Debt: 60745000.00
ORGO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 99640000.00
ORGO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
ORGO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -5173000.00
ORGO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 64585000.00
ORGO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
ORGO income_statement (annual, 2023-12-31) — Net Income: 4945000.00
ORGO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 4945000.00
ORGO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 4945000.00
ORGO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 4945000.00
ORGO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 4945000.00
ORGO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 4945000.00
ORGO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 4945000.00
ORGO income_statement (annual, 2023-12-31) — Net Interest Income: -2190000.00
ORGO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -5173000.00
ORGO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -5173000.00
ORGO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -2190000.00
ORGO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -332000.00
ORGO balance_sheet (annual, 2023-12-31) — Net PPE: 156346000.00
ORGO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -24364000.00
ORGO cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
ORGO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 234020000.00
ORGO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 28002000.00
ORGO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 28002000.00
ORGO income_statement (annual, 2023-12-31) — Normalized EBITDA: 36031000.00
ORGO income_statement (annual, 2023-12-31) — Normalized Income: 4945000.00
ORGO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 30917000.00
ORGO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 235000.00
ORGO income_statement (annual, 2023-12-31) — Operating Income: 12525000.00
ORGO income_statement (annual, 2023-12-31) — Operating Revenue: 433140000.00
ORGO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 131316396.00
ORGO balance_sheet (annual, 2023-12-31) — Other Current Assets: 5118000.00
ORGO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 5486000.00
ORGO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1087000.00
ORGO income_statement (annual, 2023-12-31) — Other Income Expense: 57000.00
ORGO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 15871000.00
ORGO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 8056000.00
ORGO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 5990000.00
ORGO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1213000.00
ORGO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 57000.00
ORGO balance_sheet (annual, 2023-12-31) — Other Properties: 40118000.00
ORGO income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
ORGO balance_sheet (annual, 2023-12-31) — Payables: 33523000.00
ORGO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 41424000.00
ORGO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 18287000.00
ORGO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
ORGO cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
ORGO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 5336000.00
ORGO income_statement (annual, 2023-12-31) — Pretax Income: 10392000.00
ORGO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
ORGO balance_sheet (annual, 2023-12-31) — Properties: 0.00
ORGO cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 1297000.00
ORGO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -24364000.00
ORGO balance_sheet (annual, 2023-12-31) — Raw Materials: 12988000.00
ORGO balance_sheet (annual, 2023-12-31) — Receivables: 81999000.00
ORGO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 106481000.00
ORGO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 23449000.00
ORGO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -5173000.00
ORGO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
ORGO income_statement (annual, 2023-12-31) — Research And Development: 44380000.00
ORGO balance_sheet (annual, 2023-12-31) — Restricted Cash: 498000.00
ORGO balance_sheet (annual, 2023-12-31) — Retained Earnings: -40971000.00
ORGO income_statement (annual, 2023-12-31) — Selling General And Administration: 269754000.00
ORGO balance_sheet (annual, 2023-12-31) — Share Issued: 132044944.00
ORGO income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
ORGO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 8996000.00
ORGO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 278663000.00
ORGO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 234020000.00
ORGO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ORGO income_statement (annual, 2023-12-31) — Tax Provision: 5447000.00
ORGO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
ORGO balance_sheet (annual, 2023-12-31) — Total Assets: 460025000.00
ORGO balance_sheet (annual, 2023-12-31) — Total Capitalization: 339408000.00
ORGO balance_sheet (annual, 2023-12-31) — Total Debt: 119351000.00
ORGO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 278663000.00
ORGO income_statement (annual, 2023-12-31) — Total Expenses: 420615000.00
ORGO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 181362000.00
ORGO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 234981000.00
ORGO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 100853000.00
ORGO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 12525000.00
ORGO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 2799000.00
ORGO income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
ORGO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ORGO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 728548.00
ORGO balance_sheet (annual, 2023-12-31) — Work In Process: 810000.00
ORGO balance_sheet (annual, 2023-12-31) — Working Capital: 144535000.00
ORGO income_statement (annual, 2023-12-31) — Write Off: 0.00
ORGO balance_sheet (quarterly, 2024-09-30) — Current Debt: 5964000.00
ORGO income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
ORGO income_statement (quarterly, 2024-09-30) — Interest Expense: 471000.00
ORGO income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 471000.00
ORGO balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 56153000.00
ORGO balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 5964000.00
ORGO income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: 471000.00
ORGO income_statement (annual, 2024-12-31) — +Operating Expense: 344784000.00
ORGO income_statement (annual, 2024-12-31) — +Total Revenue: 482043000.00
ORGO balance_sheet (annual, 2024-12-31) — Accounts Payable: 28911000.00
ORGO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 109861000.00
ORGO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -72949000.00
ORGO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -72949000.00
ORGO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 302994000.00
ORGO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -9576000.00
ORGO cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 3403000.00
ORGO cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 3403000.00
ORGO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 22801000.00
ORGO balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
ORGO income_statement (annual, 2024-12-31) — Basic Average Shares: 131673278.00
ORGO income_statement (annual, 2024-12-31) — Basic EPS: -0.01
ORGO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 104338000.00
ORGO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 13600000.00
ORGO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 13600000.00
ORGO cash_flow (annual, 2024-12-31) — Capital Expenditure: -10032000.00
ORGO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 43312000.00
ORGO balance_sheet (annual, 2024-12-31) — Capital Stock: 122432000.00
ORGO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 135571000.00
ORGO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 135571000.00
ORGO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 27637000.00
ORGO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -10032000.00
ORGO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 14208000.00
ORGO cash_flow (annual, 2024-12-31) — Change In Account Payable: -2372000.00
ORGO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 9164000.00
ORGO cash_flow (annual, 2024-12-31) — Change In Inventory: -6204000.00
ORGO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -1062000.00
ORGO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -14066000.00
ORGO cash_flow (annual, 2024-12-31) — Change In Payable: -2372000.00
ORGO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 6792000.00
ORGO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -2549000.00
ORGO cash_flow (annual, 2024-12-31) — Change In Receivables: -31800000.00
ORGO cash_flow (annual, 2024-12-31) — Change In Working Capital: -48889000.00
ORGO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -31800000.00
ORGO cash_flow (annual, 2024-12-31) — Changes In Cash: 31813000.00
ORGO balance_sheet (annual, 2024-12-31) — Common Stock: 13000.00
ORGO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 262897000.00
ORGO cash_flow (annual, 2024-12-31) — Common Stock Payments: -25479000.00
ORGO balance_sheet (annual, 2024-12-31) — Construction In Progress: 21887000.00
ORGO balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 21887000.00
ORGO income_statement (annual, 2024-12-31) — Cost Of Revenue: 115741000.00
ORGO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 9881000.00
ORGO balance_sheet (annual, 2024-12-31) — Current Assets: 285941000.00
ORGO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 9113000.00
ORGO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 9113000.00
ORGO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
ORGO balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
ORGO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
ORGO balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 0.00
ORGO balance_sheet (annual, 2024-12-31) — Current Liabilities: 77477000.00
ORGO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -10719000.00
ORGO cash_flow (annual, 2024-12-31) — Deferred Tax: -10719000.00
ORGO cash_flow (annual, 2024-12-31) — Depreciation: 21971000.00
ORGO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 25374000.00
ORGO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 25374000.00
ORGO income_statement (annual, 2024-12-31) — Diluted Average Shares: 131673278.00
ORGO income_statement (annual, 2024-12-31) — Diluted EPS: -0.01
ORGO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -937000.00
ORGO income_statement (annual, 2024-12-31) — EBIT: -1263000.00
ORGO income_statement (annual, 2024-12-31) — EBITDA: 24111000.00
ORGO cash_flow (annual, 2024-12-31) — End Cash Position: 136151000.00
ORGO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 27637000.00
ORGO balance_sheet (annual, 2024-12-31) — Finished Goods: 12044000.00
ORGO cash_flow (annual, 2024-12-31) — Free Cash Flow: 4176000.00
ORGO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 1140000.00
ORGO balance_sheet (annual, 2024-12-31) — Goodwill: 28772000.00
ORGO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 41240000.00
ORGO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 119437000.00
ORGO balance_sheet (annual, 2024-12-31) — Gross PPE: 199187000.00
ORGO income_statement (annual, 2024-12-31) — Gross Profit: 366302000.00
ORGO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 18842000.00
ORGO income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
ORGO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 6965000.00
ORGO cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 1472000.00
ORGO income_statement (annual, 2024-12-31) — Interest Expense: 1544000.00
ORGO income_statement (quarterly, 2024-12-31) — Interest Expense: -61000.00
ORGO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1544000.00
ORGO income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: -61000.00
ORGO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 4970000.00
ORGO cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 865000.00
ORGO balance_sheet (annual, 2024-12-31) — Inventory: 26219000.00
ORGO balance_sheet (annual, 2024-12-31) — Invested Capital: 262897000.00
ORGO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -10032000.00
ORGO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 120688000.00
ORGO balance_sheet (annual, 2024-12-31) — Leases: 63342000.00
ORGO balance_sheet (quarterly, 2024-12-31) — Leases: 63342000.00
ORGO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 34199000.00
ORGO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 34199000.00
ORGO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -67644000.00
ORGO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 63248000.00
ORGO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 63248000.00
ORGO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -25479000.00
ORGO income_statement (annual, 2024-12-31) — Net Income: 861000.00
ORGO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -937000.00
ORGO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 861000.00
ORGO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 861000.00
ORGO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 861000.00
ORGO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 861000.00
ORGO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 861000.00
ORGO income_statement (annual, 2024-12-31) — Net Interest Income: -1544000.00
ORGO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -67644000.00
ORGO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -67644000.00
ORGO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1544000.00
ORGO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1175000.00
ORGO balance_sheet (annual, 2024-12-31) — Net PPE: 126238000.00
ORGO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -10032000.00
ORGO cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 120688000.00
ORGO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 344076000.00
ORGO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 39462000.00
ORGO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 39462000.00
ORGO income_statement (annual, 2024-12-31) — Normalized EBITDA: 46912000.00
ORGO income_statement (annual, 2024-12-31) — Normalized Income: 18873790.00
ORGO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 14208000.00
ORGO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1355000.00
ORGO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 911000.00
ORGO income_statement (annual, 2024-12-31) — Operating Income: 21518000.00
ORGO income_statement (annual, 2024-12-31) — Operating Revenue: 482043000.00
ORGO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 125730236.00
ORGO balance_sheet (annual, 2024-12-31) — Other Current Assets: 5249000.00
ORGO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1450000.00
ORGO balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 1450000.00
ORGO income_statement (annual, 2024-12-31) — Other Income Expense: -22781000.00
ORGO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 12468000.00
ORGO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 8909000.00
ORGO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 5005000.00
ORGO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 894000.00
ORGO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 20000.00
ORGO balance_sheet (annual, 2024-12-31) — Other Properties: 37110000.00
ORGO income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 412000.00
ORGO balance_sheet (annual, 2024-12-31) — Payables: 33197000.00
ORGO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 43078000.00
ORGO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 23836000.00
ORGO balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 23836000.00
ORGO balance_sheet (annual, 2024-12-31) — Preferred Stock: 122419000.00
ORGO income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 1386000.00
ORGO balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 122419000.00
ORGO cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 120688000.00
ORGO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 8461000.00
ORGO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 8461000.00
ORGO income_statement (annual, 2024-12-31) — Pretax Income: -2807000.00
ORGO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1247000.00
ORGO balance_sheet (annual, 2024-12-31) — Properties: 0.00
ORGO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
ORGO cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 3938000.00
ORGO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -10032000.00
ORGO balance_sheet (annual, 2024-12-31) — Raw Materials: 13252000.00
ORGO balance_sheet (annual, 2024-12-31) — Receivables: 109861000.00
ORGO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 115741000.00
ORGO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 25374000.00
ORGO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -67644000.00
ORGO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -25479000.00
ORGO income_statement (annual, 2024-12-31) — Research And Development: 50271000.00
ORGO balance_sheet (annual, 2024-12-31) — Restricted Cash: 580000.00
ORGO balance_sheet (annual, 2024-12-31) — Retained Earnings: -40110000.00
ORGO income_statement (annual, 2024-12-31) — Selling General And Administration: 294513000.00
ORGO balance_sheet (annual, 2024-12-31) — Share Issued: 126458784.00
ORGO income_statement (annual, 2024-12-31) — Special Income Charges: -22801000.00
ORGO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 10578000.00
ORGO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 385316000.00
ORGO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 221657000.00
ORGO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -4788210.00
ORGO income_statement (annual, 2024-12-31) — Tax Provision: -3668000.00
ORGO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
ORGO balance_sheet (annual, 2024-12-31) — Total Assets: 497886000.00
ORGO balance_sheet (annual, 2024-12-31) — Total Capitalization: 385316000.00
ORGO balance_sheet (annual, 2024-12-31) — Total Debt: 43312000.00
ORGO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 385316000.00
ORGO income_statement (annual, 2024-12-31) — Total Expenses: 460525000.00
ORGO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 112570000.00
ORGO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 211945000.00
ORGO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 35093000.00
ORGO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -1283000.00
ORGO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 4286000.00
ORGO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 4286000.00
ORGO income_statement (annual, 2024-12-31) — Total Unusual Items: -22801000.00
ORGO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -22801000.00
ORGO balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 728548.00
ORGO balance_sheet (annual, 2024-12-31) — Work In Process: 923000.00
ORGO balance_sheet (annual, 2024-12-31) — Working Capital: 208464000.00
ORGO income_statement (annual, 2024-12-31) — Write Off: 3959000.00
ORGO income_statement (quarterly, 2025-03-31) — +Operating Expense: 83149000.00
ORGO income_statement (quarterly, 2025-03-31) — +Total Revenue: 86693000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 24660000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 103320000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -76369000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 301842000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -9068000.00
ORGO cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 842000.00
ORGO cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 842000.00
ORGO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 6567000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 7033000.00
ORGO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 126295642.00
ORGO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.17
ORGO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 136151000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 0.00
ORGO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -3626000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 42633000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 125180000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 109965000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 109965000.00
ORGO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -2056000.00
ORGO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -3626000.00
ORGO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -19935000.00
ORGO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -2496000.00
ORGO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -7993000.00
ORGO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -8732000.00
ORGO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 0.00
ORGO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -2037000.00
ORGO cash_flow (quarterly, 2025-03-31) — Change In Payable: -2496000.00
ORGO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -10489000.00
ORGO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -5123000.00
ORGO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 5668000.00
ORGO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -20713000.00
ORGO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 5668000.00
ORGO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -25617000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Common Stock: 13000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 242902000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 23764000.00
ORGO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 23723000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 4982000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Current Assets: 268160000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 9258000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 9258000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 65053000.00
ORGO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -1266000.00
ORGO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -1266000.00
ORGO cash_flow (quarterly, 2025-03-31) — Depreciation: 5441000.00
ORGO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 6283000.00
ORGO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 6283000.00
ORGO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 126295642.00
ORGO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.17
ORGO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -21591000.00
ORGO income_statement (quarterly, 2025-03-31) — EBIT: -20179000.00
ORGO income_statement (quarterly, 2025-03-31) — EBITDA: -13896000.00
ORGO cash_flow (quarterly, 2025-03-31) — End Cash Position: 110534000.00
ORGO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -2056000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 14611000.00
ORGO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -23561000.00
ORGO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 19000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Goodwill: 28772000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 40398000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 112388000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 188643000.00
ORGO income_statement (quarterly, 2025-03-31) — Gross Profit: 62970000.00
ORGO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 150000.00
ORGO income_statement (quarterly, 2025-03-31) — Interest Income: 961000.00
ORGO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 961000.00
ORGO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
ORGO balance_sheet (quarterly, 2025-03-31) — Inventory: 29338000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 242902000.00
ORGO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -3626000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Leases: 63683000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 33375000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 33375000.00
ORGO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -285000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 64440000.00
ORGO income_statement (quarterly, 2025-03-31) — Net Income: -18843000.00
ORGO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -21591000.00
ORGO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -18843000.00
ORGO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -18843000.00
ORGO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -18843000.00
ORGO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -18843000.00
ORGO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -18843000.00
ORGO income_statement (quarterly, 2025-03-31) — Net Interest Income: 961000.00
ORGO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -285000.00
ORGO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -285000.00
ORGO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 961000.00
ORGO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1796000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Net PPE: 112274000.00
ORGO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -3626000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 327671000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 40728000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 40728000.00
ORGO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -7329000.00
ORGO income_statement (quarterly, 2025-03-31) — Normalized Income: -14043636.81
ORGO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -19935000.00
ORGO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 19000.00
ORGO income_statement (quarterly, 2025-03-31) — Operating Income: -20179000.00
ORGO income_statement (quarterly, 2025-03-31) — Operating Revenue: 86693000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 126853536.00
ORGO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 17935000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1173000.00
ORGO income_statement (quarterly, 2025-03-31) — Other Income Expense: -6565000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 11626000.00
ORGO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 3778000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 5834000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 897000.00
ORGO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 2000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Other Properties: 36756000.00
ORGO income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 121000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Payables: 24835000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 29817000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 24805000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 125167000.00
ORGO income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 2627000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 125167000.00
ORGO income_statement (quarterly, 2025-03-31) — Pretax Income: -25783000.00
ORGO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 25000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ORGO cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 873000.00
ORGO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -3626000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 13890000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Receivables: 103320000.00
ORGO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 23723000.00
ORGO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 6283000.00
ORGO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -285000.00
ORGO income_statement (quarterly, 2025-03-31) — Research And Development: 10640000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 569000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -58953000.00
ORGO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 72509000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Share Issued: 127582084.00
ORGO income_statement (quarterly, 2025-03-31) — Special Income Charges: -6567000.00
ORGO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3367000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 368069000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 202504000.00
ORGO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -1767636.81
ORGO income_statement (quarterly, 2025-03-31) — Tax Provision: -6940000.00
ORGO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
ORGO balance_sheet (quarterly, 2025-03-31) — Total Assets: 467394000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 368069000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Total Debt: 42633000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 368069000.00
ORGO income_statement (quarterly, 2025-03-31) — Total Expenses: 106872000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 99325000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 199234000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 34272000.00
ORGO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -26746000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 175000.00
ORGO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -6567000.00
ORGO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -6567000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 728548.00
ORGO balance_sheet (quarterly, 2025-03-31) — Work In Process: 837000.00
ORGO balance_sheet (quarterly, 2025-03-31) — Working Capital: 203107000.00
ORGO income_statement (quarterly, 2025-03-31) — Write Off: 6567000.00
ORGO income_statement (quarterly, 2025-06-30) — +Operating Expense: 83979000.00
ORGO income_statement (quarterly, 2025-06-30) — +Total Revenue: 100779000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 29723000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 120382000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -80101000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 301574000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -11153000.00
ORGO cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 841000.00
ORGO cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 841000.00
ORGO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 1746000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 5287000.00
ORGO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 126853536.00
ORGO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.10
ORGO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 110534000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 0.00
ORGO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3638000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 40816000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 127990000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 73076000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 73076000.00
ORGO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -288000.00
ORGO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3638000.00
ORGO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -32873000.00
ORGO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 4133000.00
ORGO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -5893000.00
ORGO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -7160000.00
ORGO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 34000.00
ORGO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -2110000.00
ORGO cash_flow (quarterly, 2025-06-30) — Change In Payable: 4133000.00
ORGO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -1760000.00
ORGO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -7819000.00
ORGO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -19305000.00
ORGO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -38120000.00
ORGO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -19305000.00